Thymomata are a heterogeneous spectrum of tumors arising from the epithelium of the thymus. They are categorized by their proportional composition of neoplastic epithelial cells to nonneoplastic lymphocytes and by the degree of cytologic atypia. Thymomata are generally encapsulated and noninvasive; however, integrity of the capsule is a significant determinant of prognosis. This family of tumors is also commonly associated with autoimmune paraneoplastic syndromes, most notably, myasthenia gravis. Because most are well encapsulated, surgical excision is usually curative; however, combinations of surgery, chemotherapy, and radiation may be employed for more aggressive, recurrent, or invasive cases. Presented here is a case of male infant born at 39 weeks' gestation. At birth, he was diagnosed with transient tachypnea of newborn. Chest X-ray revealed a large mediastinal mass. CT revealed a 9 x 5 x 5 cm solid, heterogeneous mass in the anterior mediastinum that displaced the heart, great vessels, and lungs without invasion or narrowing of the airway. Ultrasound-guided biopsy was performed and submitted for microscopic, flow cytometric, and molecular diagnostic analysis. Immunohistochemical staining of the biopsy revealed a majority population of immature T-cells in a background of epithelium. No microscopic features of thymic carcinoma were identified. Flow cytometry revealed an 81% population of polyclonal immature T-cells with no increased population of blasts. The mass was completely resected via median sternotomy. The mass resembled normal thymus without evidence of fibrosis or calcification. Frozen section analysis at the time of the procedure revealed architecture consistent with thymoma. Microscopic examination of permanent sections revealed loss of normal thymic architecture with a mixed B1/B2 thymoma pattern. Congenital thymoma is nearly unheard of, with very few cases described. This case reminds us that even unheard of pathologies can and do exist, and an open mind is required to reach the true diagnosis. is an uncommon neoplasm that shows low to intermediate malignant potential. It mostly affects young to middle-aged adults. The most commonly involved sites are the lymph nodes, especially the cervical lymph nodes, but extranodal sites may be involved. Methods: We describe a 22-year-old woman who was referred for consultation by an outside hospital and diagnosed with metastatic carcinoma of left axillary lymph node; she had a history of invasive ductal carcinoma of the left breast. Histology revealed a spindle cell tumor. The cells have eosinophilic cytoplasm and are arranged in whorls, admixed with small lymphocytes. Marked cellular atypia, high mitotic rate, and abnormal mitosis are noted. The cells were positive for CD21, CD23, CD35, vimentin, and epithelial membrane antigen, and negative for S100 and HMB45. Conclusion: The diagnosis of FDCS was made. Differential diagnosis includes interdigitating dendritic cell sarcoma, spindle cell carcinoma, metastatic undifferentiated carcinomas, and melanoma. Interdigitating dendritic cell sarcomas lack the storiform and whorled patterns of FDCS, and are diffusely positive for S100 and negative for CD21 and CD35. Metastatic undifferentiated carcinomas and spindle cell carcinomas express cytokeratin positivity. Melanoma is S100 and HMB positive. Currently, the etiology of FDCS is unknown. However, loss of Xp, Castleman disease, and Epstein-Barr virus may contribute. In conclusion, FDCS is a rare neoplasm; however, the frequency of FDCS is increasing, and lymphadenopathy in patients with history of cancer should be diagnosed with caution. Objectives: Acute megakaryoblastic leukemia is an uncommon disease comprising <5% of cases of acute myeloid leukemia occurring in both adults and children. Hereby, we are reporting a case of congenital AML-M7 in the infants, presenting at 3 weeks of age. Methods: We used the bone marrow examination, bone biopsy, immunophenotyping (leukemia panel), and FISH for the diagnosis and management purpose. Results: The mother of the patient noticed the following symptoms: progressive abdominal distention, irritability, fever, vomiting, and frequent loose stools in her child, over a period of one week. On further investigation findings were as follows: complete blood count Hb 6.7 mg/dL, total leukocyte count (TLC) 21,000/mm 3 , and platelet count 217,000/mm 3 . Bone marrow examination revealed 55% blasts, which were medium to large in size, with high N:C ratio, fine immature chromatin, and up to one prominent nucleolus. Bone biopsy report showed hypercellular marrow with increased numbers of blasts (42%) and moderate marrow fibrosis. On immunophenotyping, MPO, CD 13, CD 33, CD 34, and CD117 markers were positive, and HLA-DR, CD3, CD5, CD7, CD10, CD19, CD22, CD79a, and TdT markers were negative. A secondary immunophenotyping panel showed positivity for CD41a and CD61. Thus the diagnosis of acute megakaryoblastic leukemia was confirmed. FISH for BCR-ABL rearrangement showed positivity in 76% cells. Conclusion: Extensive review of the literature did not reveal much information on this rare case report, and to the best of our knowledge, this would be the probable first case report of BCR-ABL-positive congenital acute megakaryoblastic leukemia. With this report, we would like to create awareness regarding the unusual early presentation and encourage clinicians to keep a high index of suspicion of megakaryocytic leukemia even in the neonatal period.
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A Case of Follicular Lymphoma Transforming to CD5+/ CD10+ Triple-Hit Lymphoma
Liron Barnea Slonim, MD, Sherif Ibrahim, MD, PhD, Virginia Donovan, MD, FASCP, Matthew Geller, DO; Winthrop University Hospital, Mineola, NY
A 58-year-old man presented with abdominal pain, weight loss, and fatigue. Imaging showed a complex mass in the left lower quadrant involving the sigmoid colon, extensive lymphadenopathy and osseous metastases. A biopsy revealed grade 3A follicular lymphoma. Flow demonstrated bone marrow involvement, and FISH demonstrated a t(14;18)(q32;q21.3) translocation. Treatment was initiated, but three weeks later, he presented with headaches and neurologic symptoms. Intrathecal chemotherapy was started following a positive cerebrospinal fluid (CSF) evaluation. There was initial improvement; however, five months later, he had increased adenopathy and positive CSF cytology. Flow cytometry showed a CD5/CD10 double-positive large B-cell lymphoma. FISH identified a t(14;18) translocation involving the IGH-BCL2 genes, rearrangement of MYC, and rearrangement of BCL6, consistent with triple-hit diffuse large B-cell lymphoma. The patient's course was further complicated with neutropenic sepsis and admission to the medical intensive care unit. Double-hit lymphomas (DHLs) are aggressive neoplasms with translocations involving the MYC gene combined with another event involving translocation of the BCL2 or BCL6 gene. The combination of MYC translocation with translocations of BCL2 and BCL6 are defined as triple-hit lymphomas (THLs). These neoplasms typically present in older men, with extranodal involvement, mostly in the head and neck region and gastrointestinal tract. They are usually CD10+, BCL6+, and BCL2+, with 50% being IRF4/MUM1+. A recent study observed that both BCL-2 and MYC gene gain/amplification were strong independent indicators of central nervous system involvement in DLBCL. It was reported as a predictor of poor clinical behavior and survival. To our knowledge, this is the first reported case of a double-or triple-hit DLBCL acquiring CD5 positivity as a secondary event. The aggressive features, resistance to therapy and leptomeningeal spread concur with previously reported characteristics. The field of the DHL/ THL large B-cell lymphomas is becoming more complex. Future studies should help to their rapid recognition and improved patient outcomes. Distinguishing neoplastic from reactive cutaneous lymphoid infiltrates remains a diagnostic challenge. While flow cytometry is broadly used in hematopathology, it is only now emerging as a method for determining the immunophenotype and clonality of cutaneous lymphocyte populations. Cutaneous marginal zone lymphomas are particularly challenging; these cases often have lymphoid follicles with reactive features, and the neoplastic cells can be greatly outnumbered by the associated reactive, polyclonal B-and T-lymphocyte populations. We present the case of a 53-year-old man who presented with a three-year history of a patch on the left cheek. Two biopsies, taken a year apart, showed a dense nodular superficial and deep perivascular, perifollicular, and peri-eccrine mixed lymphoid infiltrate (60% B-cells and 40% T-cells), composed mainly of small lymphocytes with focal reactive germinal centers. These findings were initially interpreted as being most consistent with a reactive process, or pseudolymphoma. Because the lesion failed to regress after multiple steroid injections, a third biopsy was taken. Although this specimen had similar morphologic features, flow cytometry was performed and revealed a small abnormal B-cell population comprising 1.14% of total white blood cells. These B-cells showed abnormal expression of CD11c and were lambda light chain restricted with normal expression of CD19, CD20, CD38, and CD45 without CD5, CD10, or CD43. In addition, a small lambda light chain restricted plasma cell population was identified (0.01% of total white blood cells). No abnormal T-cells were identified. Molecular studies confirmed the presence of a clonal immunoglobulin gene rearrangement.
